Info

DFB Pharmaceuticals, Inc. is a fully integrated specialty pharmaceutical company whose synergistic businesses provide the key to our success. Our operating companies - DPT Laboratories Ltd., Healthpoint Ltd., Coria Laboratories Ltd. and Phyton Biotech, Inc. - uniquely position DFB to meet the needs of a growing market in contract research and manufacturing, while also providing the infrastructure to drive the company's efforts as a leader in branded pharmaceuticals and advanced medical products. Important to our future growth is the expansion of key business segments through internal research and development and mutually beneficial partnering. DPT Laboratories, Ltd. is the industry choice for semi-solid and liquid development and manufacturing services for the world's leading pharmaceutical, biotechnology and healthcare companies. DPT has facilities in San Antonio, Texas, and Lakewood, New Jersey, with over one million square feet of combined state-of-the-art research and development, manufacturing, packaging and distribution space. Healthpoint, Ltd., headquartered in Fort Worth, Texas, is a specialty pharmaceutical company uniquely committed to the prevention and treatment of diseased and traumatized skin and related soft tissue. Our two divisions, Tissue Management and Surgical, develop and market innovative, quality biologic, pharmaceutical and medical products for the benefit of patients and medical professionals. CORIA Laboratories, Ltd. develops and markets high-quality products for the treatment of diseases affecting the skin, hair and nails. Based in Fort Worth, Texas, Coria specializes in dermatology and is firmly committed to delivering innovative products to dermatologists and other related healthcare professionals. The name Coria itself is derived from the Latin word "corium," meaning "the true skin." Phyton Biotech, Inc., located in Princeton, New Jersey, is a world leader in plant cell culture technology. The company's proprietary plant cell fermentation (PCF) technology provides an integrated platform designed to meet customer needs involving plants as a source for novel drugs. Phyton also operates the world's largest plant cell culture production site in a 48,000-square-foot facility in Ahrensburg, Germany.